Our previous study showed that CTNNB1 (58%) and TP53 (19%) were ranked as the two most mutated genes in our cohort of HBV-related HCC patients14, which was further validated in TCGA HCC database (Supplementary Fig. S2a). This evidence concerns the gene TP53 and hepatocellular carcinoma.